NHS in England to offer pioneering cancer drug to patients with ‘Jolie gene’ – The Guardian
“This is a momentous development in the treatment of cancers linked to faulty BRCA1 and BRCA2 genes,” said Prof Kristian Helin, the ICR chief …
“This is a momentous development in the treatment of cancers linked to faulty BRCA1 and BRCA2 genes,” said Prof Kristian Helin, the ICR chief …
